13.3
Acurx Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
9.38
FY23:
7.71
FY24:
3.86
FY25:
7.69
(positive)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
13.3
FY22:
9.38
FY23:
7.71
FY24:
3.86
FY25:
7.69
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.84
FY22:
2.06
FY23:
3.04
FY24:
3.24
FY25:
2.42
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
12.4
FY22:
7.32
FY23:
4.67
FY24:
0.62
FY25:
5.27
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
13.3
FY22:
9.38
FY23:
7.71
FY24:
3.86
FY25:
7.69
All amounts in millions USD